Drugs and Devices

FDA approves Corlanor for treatment of heart failure

On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares